NOTES Transvaginal Cholecystectomy and Appendectomy
2 other identifiers
interventional
6
1 country
2
Brief Summary
Natural Orifice Translumenal Endoscopic Surgery (NOTES) is considered by many leading expert surgeons to be the next step in MIS (Minimally Invasive Surgery). This is a rapidly evolving area of preclinical research and several groups worldwide are developing this surgical approach together with industry support. In this new surgical technique, abdominal operations are performed using the oropharynx, rectum, or vagina as the ports of entry to the peritoneal cavity instead of incisions on the abdominal wall. NOTES offers all the advantages of minimally invasive surgery (MIS) and also completely eliminates trauma to the abdominal wall and the numerous complications of abdominal wall incisions. A NOTES procedure eliminates any visible scar and could also potentially reduce post operative pain due to the elimination of abdominal wall trauma. In this trial we intend to operate healthy women who need to undergo cholecystectomy or appendectomy. The operations will be performed through the vagina as the access port to the peritoneum and it will be monitored with laparoscopic vision for safety reasons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2008
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2007
CompletedFirst Posted
Study publicly available on registry
November 1, 2007
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJuly 30, 2020
April 1, 2016
9.6 years
October 31, 2007
July 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL APPROACH TO MINIMALLY INVASIVE SURGICAL TECHNIQUES
continuous
Secondary Outcomes (1)
TO ASSESS PAIN ASSOCIATED WITH TRANSVAGINAL APPROACH
continuous
Study Arms (2)
1
ACTIVE COMPARATORNOTES Transvaginal cholecystectomy The gallbladder will be dissected free and will be removed through an incision in the vagina.
2
ACTIVE COMPARATORNOTES Transvaginal Appendectomy. The appendix will be dissected free and will be removed through an incision in the vagina.
Interventions
The gallbladder will be dissected free and will be removed through an incision in the vagina.
The appendix will be dissected free and will be removed through an incision in the vagina.
Eligibility Criteria
You may qualify if:
- Females between the ages of 18 and 50
- Diagnosis of gallstone disease which requires cholecystectomy
- ASA class 1
You may not qualify if:
- Pregnant women
- Morbidly obese patients (BMI \> 35)
- Patients who are taking immunosuppressive medications and/or immunocompromised
- Patients with severe medical comorbidities will be excluded.
- Patients with a presumed gallbladder polyps, mass or tumor
- Patients with a history of prior open abdominal or transvaginal surgery.
- Patients with a prior history of peritoneal or vaginal trauma
- Patients with a history of ectopic pregnancy, pelvic inflammatory disease, or severe endometriosis
- Patients with known common bile duct stones
- Patients on blood thinners or aspirin or abnormal blood coagulation tests
- Clinical diagnosis of appendicitis
- Emergency room evaluation within 36 hours of the onset of pain
- ASA Classification
- pregnant women
- Morbidly obese patients (BMI \>35)
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hadassah Medical Center
Jerusalem, 12000, Israel
Hadassah Medical Organization
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yoav Mintz, MD
Hadassah Medical Organization
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2007
First Posted
November 1, 2007
Study Start
June 1, 2008
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
July 30, 2020
Record last verified: 2016-04